ALEXANDRA FISCHER: Open Payments
NPI 1780330118 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,378 in 222 payments from 20 companies in 2025. Trend: 2023 $2,205 · 2024 $3,292 · 2025 $3,378
Food & beverage: $3,373Education: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $566 |
| Regeneron Healthcare Solutions, Inc. | 22 | $527 |
| Galderma Laboratories, L.P. | 36 | $462 |
| Arcutis Biotherapeutics, Inc. | 43 | $441 |
| GENZYME CORPORATION | 13 | $284 |
| Incyte Corporation | 15 | $250 |
| Amgen Inc. | 13 | $202 |
| PFIZER INC. | 15 | $157 |
| Janssen Biotech, Inc. | 5 | $89 |
| Botanix SB Inc | 5 | $82 |
Products named: DUPIXENT, Zoryve, NEMLUVIO, SKYRIZI, OPZELURA, OTEZLA, RINVOQ, CIBINQO.
Industry payments across TX — which companies pay providers there.
